Kwang Dong Pharmaceutical Co., Ltd. (KRX: 009290)

Kwang Dong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	71,877	77,344	103,552	83,966	54,882	76,280
Short-Term Investments	-	-	-	9,369	-	0
Trading Asset Securities	89,033	128,837	105,080	94,366	94,392	35,720
Cash & Short-Term Investments	160,910	206,181	208,632	187,701	149,273	112,000
Cash Growth	-29.80%	-1.17%	11.15%	25.74%	33.28%	-7.12%
Accounts Receivable	277,912	256,830	224,530	237,863	223,107	233,065
Other Receivables	4,885	5,513	2,734	3,568	2,874	3,003
Receivables	282,923	262,402	227,311	241,486	226,039	236,137
Inventory	217,379	188,643	161,410	152,493	171,349	146,953
Prepaid Expenses	1,163	1,766	2,017	2,370	2,868	2,198
Other Current Assets	5,925	6,432	6,376	3,769	34,966	4,888
Total Current Assets	668,300	665,424	605,747	587,818	584,494	502,175
Property, Plant & Equipment	235,541	212,432	153,532	138,013	124,679	137,815
Long-Term Investments	125,341	96,139	93,686	83,604	82,425	52,737
Goodwill	-	21,694	6,119	6,119	6,119	6,119
Other Intangible Assets	38,052	15,008	9,975	10,592	6,254	10,303
Long-Term Deferred Tax Assets	11,439	12,960	10,536	8,365	8,151	8,875
Other Long-Term Assets	54,654	52,214	50,247	46,982	17,554	73,836
Total Assets	1,135,603	1,078,065	932,024	883,845	830,643	792,776
Accounts Payable	172,706	171,051	174,051	153,527	156,136	159,119
Accrued Expenses	1,641	1,862	1,691	1,079	961.74	1,098
Short-Term Debt	240,807	187,834	113,006	93,006	83,005	75,006
Current Portion of Long-Term Debt	2,122	24,202	-	15,000	9,993	8,333
Current Portion of Leases	2,733	1,913	1,362	1,109	1,070	2,113
Current Income Taxes Payable	4,929	8,941	8,338	10,179	9,279	8,846
Current Unearned Revenue	288.51	291.6	331.8	331.4	273	142.55
Other Current Liabilities	58,134	60,714	54,786	51,263	41,470	53,705
Total Current Liabilities	483,361	456,810	353,567	325,495	302,187	308,362
Long-Term Debt	28,042	19,028	21,962	21,934	15,000	24,976
Long-Term Leases	4,672	2,664	1,675	997.64	636.78	1,719
Long-Term Deferred Tax Liabilities	3,493	2,173	1,675	2,717	5,735	2,069
Other Long-Term Liabilities	10,586	9,344	6,099	5,457	4,891	7,748
Total Liabilities	530,153	490,018	384,978	356,600	328,462	345,319
Common Stock	52,421	52,421	52,421	52,421	52,421	52,421
Additional Paid-In Capital	55,325	55,299	55,277	55,223	55,223	52,723
Retained Earnings	500,670	485,155	453,838	433,215	411,806	369,269
Treasury Stock	-53,057	-53,057	-46,822	-46,822	-46,822	-53,015
Comprehensive Income & Other	6,978	4,798	2,616	5,140	5,033	1,564
Total Common Equity	562,337	544,616	517,331	499,177	477,661	422,961
Minority Interest	43,113	43,431	29,716	28,068	24,520	24,496
Shareholders' Equity	605,450	588,047	547,046	527,245	502,182	447,457
Total Liabilities & Equity	1,135,603	1,078,065	932,024	883,845	830,643	792,776
Total Debt	278,376	235,641	138,006	132,046	109,705	112,146
Net Cash (Debt)	-117,465	-29,460	70,627	55,655	39,568	-146.42
Net Cash Growth	-	-	26.90%	40.65%	-	-
Net Cash Per Share	-2930.97	-727.94	1719.22	1353.21	976.33	-3.69
Filing Date Shares Outstanding	40.08	40.08	41.08	41.08	41.08	39.58
Total Common Shares Outstanding	40.08	40.08	41.08	41.08	41.08	39.58
Working Capital	184,939	208,615	252,180	262,323	282,307	193,813
Book Value Per Share	14030.15	13588.02	12593.06	12151.16	11627.42	10686.08
Tangible Book Value	524,285	507,915	501,237	482,467	465,288	406,539
Tangible Book Value Per Share	13080.75	12672.32	12201.30	11744.38	11326.22	10271.18
Land	-	74,423	65,921	65,840	52,823	52,881
Buildings	-	95,003	77,283	75,616	73,146	73,103
Machinery	-	152,469	129,099	124,756	120,231	118,039
Construction In Progress	-	52,582	23,534	5,237	1,725	473.45

Source: S&P Capital IQ. Standard template. Financial Sources.